Our findings demonstrate the key role of ZEB1 in EMT in cultured BCD cells, and suggest that ZEB1 inhibition may contribute to protocols of BCD cell redifferentiation, aimed at generating functional human β-like cells for cell therapy of diabetes. Here, ZEB1 is linked to diabetes mellitus.